BioSpace News Archive

Alkermes plc announced that Jim Robinson, President and Chief Operating Officer, has resigned from his position and will leave the company, effective April 19, 2019, for personal reasons.

Digital Boom and Millennials are Growing the Category, Wellness and Self-Care are New Key Drivers, Interest is in Eyes and Body Contouring

“THIS SHIRT SAVES LIVES” Movement Takes Over Nissan Stadium to Support St. Jude, Gives Unforgettable Experiences to St. Jude Families in Attendance

Based on its exclusive license related to photoimmunotherapy, Rakuten Medical Inc., which is developing a cancer therapy to target cancer cells, announced that ASP-1929 received Sakigake designation under the Sakigake Designation System*, which is a Fast Track designation from the Japanese Ministry of Health, Labour, and Welfare as a treatment for head and neck cancer patients.

LSK BioPharma and Jiangsu Hengrui Medicine, Co., Ltd. announced that the Companies have received FDA clearance to initiate a clinical trial in the United States

Uni-Bio Science Group Limited is pleased to announce the appointment of Mr. Zhao Zhi Gang as the CEO, Mr. Ma Qing Shan as independent non-executive director and Mr. Tony Yau as non-executive director of the Group, effective on 8 April 2019.

Under the terms of the agreement, Regeneron is paying $400 million upfront to Alnylam and acquiring another $400 million in equity at a price per share of $90, or 4.44 million common shares.

In early March, Allergan reported that rapastinel, its experimental adjunctive treatment for major depressive disorder, failed to hit endpoints in a late-stage trial.

Celgene and its developmental partner Acceleron Pharma are eying a potential U.S. Food and Drug Administration approval of a blood-disease treatment.

San Francisco-based Audentes Therapeutics signed a licensing agreement and collaboration deal with Nationwide Children’s Hospital to expand its pipeline for vectorized antisense treatments for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1).